Supporting primary care to recognise cancer in the COVID-19 era
Dr Anthony Cunliffe discusses barriers to cancer diagnosis and investigations imposed by the pandemic and how to overcome them
Top tips: mental health and cancer in adults
Dr Sadaf Haque offers 10 top tips for primary care on the identification and management of mental health problems in adults with cancer
Top tips: colorectal cancer
Dr Richard Roope provides top tips for GPs about identifying possible colorectal cancer and supporting patients to reduce risk and achieve the best outcomes
Top tips: personalising cancer care
Dr Anthony Cunliffe shares 10 top tips for primary care on the provision of personalised care for people with cancer
Unintended weight loss: what’s the diagnosis?
Dr Sonya Jey explains the importance of considering and excluding sinister causes of unintentional weight loss and explores some clinical scenarios in which unintentional weight loss is a feature
Top tips: lung cancer
Dr Anthony Cunliffe and Dr Richard Simcock share 10 top tips for primary care on the diagnosis and management of patients with lung cancer
Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.
Best practice in pancreatic cancer
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on pancreatic cancer in primary care—you will then be prompted to reflect on your learning.
A cancer diagnosis can be overwhelming – Macmillan’s email support can help your patients.
Your patients can sign up for regular tailored emails from Macmillan to support them through diagnosis and beyond. With information ranging from treatment to the impact of cancer on money and work, tell your patients to sign up today. Learn more here
Educational resources
Prostap® DCS (leuprorelin acetate)—a 3-monthly gonadotrophin-releasing hormone (GnRH) agonist treatment for breast cancer
Information intended for UK healthcare professionals only. This round-table discussion supplement has been commissioned and funded by Takeda UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
C-APROM/UK/PRS/0152
Date of preparation: April 2021
Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK
This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021
PROSTAP® DCS (leuprorelin acetate)
This formulary decision guide was developed by Guidelines in Practice based on content and funding provided by Takeda UK Ltd. Information intended for healthcare professionals only.
View prescribing information here
C-APROM/UK/LEU/0075 February 2021
Related Guidelines summaries
-
COVID-19 rapid guideline on systemic anticancer treatments
This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection
-
NICE suspected cancer in primary care guideline
A summary of guidance to assist GPs on the recognition and referral of suspected cancer
-
PHE PSA prostate cancer test guideline
A concise summary of PHE's guidance on PSA testing in men over 50 years old. Includes a useful algorithm.
-
NICE breast cancer guideline
An easy-to-read NICE guidance summary on the classification and care of people at risk of familial breast cancer or with a family history of breast cancer.
-
Cancer referral guideline
This easy-to-use summary covers the recognition, referral, and investigation of people who may have cancer.